buy medicine online indiamedicine onlineloading...


    Information about Reboxetine

    Reboxetine uses

    Reboxetine is used in the treatment of depression.

    How reboxetine works

    Reboxetine works in depression by increasing the levels of chemical messengers in the brain that helps in regulating mood.

    Common side effects of reboxetine

    Insomnia (difficulty in sleeping), Dryness in mouth, Nausea, Dizziness, Constipation
    Content Details
    Written By
    Dr. Swati Mishra
    Reviewed By
    Dr. Shilpa Garcha
    MD (Pharmacology), MBBS
    Last updated on:
    27 Dec 2019 | 01:08 PM (IST)
    Want to know more?
    Read Our Editorial Policy

    Available Medicine for Reboxetine

    • ₹30 to ₹108
      3 variant(s)
    • ₹16 to ₹30
      Intas Pharmaceuticals Ltd
      2 variant(s)
    • ₹17 to ₹34
      Wockhardt Ltd
      2 variant(s)
    • ₹26 to ₹49
      Zydus Cadila
      2 variant(s)

    Expert advice for Reboxetine

    • Reboxetine is not recommended for children and adolescents < 18 years of age.
    • Seek immediate medical advice if you develop suicide-related behaviors and hostility (predominantly aggression, oppositional behavior and anger).
    • Use reboxetine with caution if you are suffering from seizures (fits) and you should discontinue reboxetine if you develop seizures.
    • Do not drive or operate machinery as reboxetine may make you feel dizzy.
    • Tell your doctor if you are or planning to become pregnant or are breastfeeding.

    Frequently asked questions for Reboxetine


    Q. Is Reboxetine an SSRI/ a stimulant/ good for anxiety?

    Reboxetine is an antidepressant that belongs to class of medicines called norepinephrine reuptake inhibitors. It is not a stimulant and it is used in acute treatment of depressive illness including major depression

    Q. Does Reboxetine cause weight gain/ weight loss?

    Reboxetine is not known to cause weight gain or loss. However, please consult your doctor regarding its use.

    Content on this page was last updated on 27 December, 2019, by Dr. Varun Gupta (MD Pharmacology)